Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.46

-0.42

-0.37

-0.32

Details

Expected EPS

-0.383333

Actual EPS

-0.32

Surprise EPS

0.06

Surprise Percent

+16.52%

Description

Fate Therapeutics (FATE) has reported earnings of -0.32 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.